Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australian Biotech Faces Perfect Storm

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - Investment in Australia's biotech sector plummeted to AU$183 million in 2008, down from AU$ 943 million in 2007, AusBiotech reported

You may also be interested in...



What Financial Crisis? Australian Biotech Enters Golden Era (Part 1 of 2)

PERTH, Australia - Australia's biotech sector has entered a golden era, with its top 20 companies now maturing, for the first time bringing products to late-stage development, and looking to commercialize

What Financial Crisis? Australian Biotech Enters Golden Era (Part 1 of 2)

PERTH, Australia - Australia's biotech sector has entered a golden era, with its top 20 companies now maturing, for the first time bringing products to late-stage development, and looking to commercialize

Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotechs In 2009 Budget

“This will be the first time in 21 years that there will be no dedicated industry support program to promote investment in this valuable knowledge-based industry,” Medicines Australia exec warns..

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel